GlobalData looks at how robotics is changing the future of minimally invasive surgery, as companies help accelerate innovation and gain market share
Following the success of minimally invasive surgery (MIS) for a number of indications and surgical specialties, medical device companies are increasingly turning to surgical robotics as the
next big innovation to solve the limitations still present in MIS procedures. In this context, data and analytics company GlobalData, believes that the surgical robotics market will become more crowded and grow to support a wider variety of surgical procedures.
The systems for robotic-assisted surgical procedures are experiencing increased interest globally. They exist for an array of indications, from a variety of general surgery procedures to orthopaedic knee replacement procedures.
The competitive landscape for surgical robotics is vast, with both large multinational corporations and small start-ups venturing into the space. Among these, Intuitive Surgical occupies the top position in the global surgical robotics market since the FDA approval of the company’s first generation da Vinci system in 2000.
Following Intuitive Surgical’s success, global competitors including Medtronic, Johnson & Johnson, and Stryker have either partnered with or acquired surgical robotics companies to help accelerate robotic innovation and gain market share.
Jennifer Ryan, medical devices analyst at GlobalData, says: “While robotic-assisted surgery aims to provide increased precision and control to a complicated procedure, they are generally very expensive to procure. On the other hand, the majority of companies at the forefront of surgical robotics systems are start-ups, which are reliant on funding and capital raisings for continued advancement.”
Over the past year, several surgical robotics players including Titan Medical, Medrobotics and Accuray have announced capital raisings through public offerings or private share placements. The largest deals have assisted CMR Surgical, Corindus Vascular Robotics and Mazor Robotics.
In September 2017, Mazor Robotics completed the third tranche of private share placement for $40m, for a total of $72m. The offering also brings Medtronic’s total investment in Mazor to $125m. According to GlobalData, surgical robotics companies raised a total of $296.1m between July 2017 and July 2018.
As the market’s growth potential continues to rise, more large multinational players are expected to invest in the surgical robotics space through acquisitions and partnerships in the coming years.
Ryan concludes: “Improvements in surgical procedures through the use of robotics will increase the patient population eligible for treatment and reduce complications and negative outcomes. As partnerships and funding continue to support innovation in the surgical robotics market, the competitive landscape will become more crowded and the market will continue to grow to support a wider variety of surgical procedures and patients.”